Meetings - The ASCO Post

Anita Mamtani, MD, of Memorial Sloan Kettering Cancer Center, discusses study findings showing that axillary lymph node dissection was required by less than 2% of patients with cT1NO triple-negative o...

breast cancer

By The ASCO Post Staff / 2023 Society of Surgical Oncology International Conference on Surgical Cancer Care

Kari M. Rosenkranz, MD, on Breast Cancer: Impact of Breast Conservation on Local Recurrence

Kari M. Rosenkranz, MD, of Dartmouth Health, discusses findings from the ACOSOG Z11102 (Alliance) study, which showed that breast-conserving therapy is safe for patients with multiple ipsilateral brea...

breast cancer

By The ASCO Post Staff / 2023 Society of Surgical Oncology International Conference on Surgical Cancer Care

Judy C. Boughey, MD, on Changes in Axillary Surgical Management: An I-SPY2 Analysis

Judy C. Boughey, MD, of the Mayo Clinic, discusses the decrease, over the past decade, of axillary lymph node dissection, especially in patients with node-positive breast cancer at diagnosis who had s...

2023 Society of Surgical Oncology International Conference on Surgical Cancer Care

Anita Mamtani, MD, on Axillary Dissection: For What Types of Breast Cancer Can It Be Avoided?

Kari M. Rosenkranz, MD, on Breast Cancer: Impact of Breast Conservation on Local Recurrence

Judy C. Boughey, MD, on Changes in Axillary Surgical Management: An I-SPY2 Analysis

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

FDA Grants Accelerated Approval to Zanidatamab-hrii for Previously Treated Unresectable or Metastatic HER2-Positive Biliary Tract Cancer

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma